Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Protalix Biotherapeutics Inc (PLX)

99 + Investors. Track Smart Money conviction in PLX. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +18
Streak
3Q ▲
Buyers last Q
64%

Smart Money Signals — PLX

Based on 100 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added PLX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
100 hedge funds hold PLX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +56% more funds vs a year ago

fund count last 6Q
+36 new funds entered over the past year (+56% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 64% buying

55 buying31 selling
Last quarter: 55 funds were net buyers (28 opened a brand new position + 27 added to an existing one). Only 31 were sellers (21 trimmed + 10 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+16 vs last Q)

new funds entering per quarter
Funds opening a new PLX position: 28 → 17 → 12 → 28. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

46% of holders stayed for 2+ years

46% conviction (2yr+) 26% medium 28% new
46 out of 100 hedge funds have held PLX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +37% but shares only +14% — price-driven

Value
+36%
Shares
+13%
Last quarter: the total dollar value of institutional holdings rose +37%, but actual share count only changed +14%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
➡️

Steady discovery — ~28 new funds/quarter

23 → 28 → 17 → 12 → 28 new funds/Q
New funds entering each quarter: 28 → 17 → 12 → 28. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 61% veterans vs 28% newcomers

61% veterans 11% 1-2yr 28% new
Entry-cohort mix of 105 holders: 64 (61%) are 2+ year veterans, 12 entered 1–2 years ago, and 29 (28%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.

Strong quality — 29% AUM from major funds

29% from top-100 AUM funds
30 of 99 holders rank in the top 100 by AUM, accounting for 29% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.4
out of 10
Moderate Exit Risk
Exit risk score 4.4/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — PLX

In 2026 Q1, 55 hedge funds were net buyers of PLX (28 opened a new position, 27 added to an existing one), while 31 reduced or exited (21 trimmed, 10 sold completely) — a 64% buyer ratio, indicating clear institutional accumulation. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 29% of total institutional value in PLX is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +18 funds (more new holders than closures). Total institutional holders: 100.

Hedge Fund Ownership: PLX

How many hedge funds hold PLX — quarterly history vs. share price
Quarterly hedge fund ownership of PLX vs. share price

Market Analysis: PLX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: PLX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Protalix Biotherapeutics Inc (PLX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much PLX has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 12d ago
PLX
+4.7%
XLV
+1.4%

PLX outperformed XLV by +3.3% since June 30, 2026.

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

11 top-rated funds 0 high-conviction
Consensus
4.7
/ 10
breadth
×
Elite
0.1
/ 10
conviction
Hedge Fund Positioning: PLX
2026 Q2 Stats Unlock in 38 days 99 + Investors

Track Smart Money conviction in PLX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 99 82 20.73%
13F Shares 17M 15M 13.9%
Total Value $37M $27M 36.57%
New Positions 27 12 +15
Increased Positions 26 29 -3
Closed Positions 10 6 +4
Reduced Positions 21 22 -1
Total Calls 3 1 200.0%
Total Puts 3 1 200.0%
PUT/CALL Ratio 1.0 1.0 Neutral

Statistics: PLX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

99 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in PLX. Verified SEC 13F-HR filings.

QUARTER:
Top 1 PLX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 GAMMA Investing LLC 0.00% 355
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Protalix Biotherapeutics Inc (PLX)

What does the Smart Money Trend signal show for PLX?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added PLX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for PLX?

More buyers than sellers — 64% buying: Last quarter: 55 funds were net buyers (28 opened a brand new position + 27 added to an existing one). Only 31 were sellers (21 trimmed + 10 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for PLX holders?

Strong quality — 29% AUM from major funds: 30 of 99 holders rank in the top 100 by AUM, accounting for 29% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held PLX?

46% of holders stayed for 2+ years: 46 out of 100 hedge funds have held PLX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Protalix Biotherapeutics Inc (PLX) following the 2026 Q2 hedge fund 13F filings?

Since the quarter end (June 30, 2026), PLX has gained +4.7% vs +1.4% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →